Monon Bioventures LLC has received a one-year, $398,314 Phase I Small Business Innovation Research, or SBIR grant from the National Cancer Institute to demonstrate the feasibility of manufacturing a glioblastoma therapeutic created at the Purdue University College of Pharmacy.
Monon Bioventures LLC has received a one-year, $398,314 Phase I Small Business Innovation Research, or SBIR, grant from the National Cancer Institute to demonstrate the feasibility of manufacturing a glioblastoma therapeutic created at the Purdue University College of Pharmacy.
The 17th Annual Garnet E. Peck Symposium will be held April 7 by the Department of Industrial and Physical Pharmacy with corporate support from Aprecia, Catalent Biologics and MED Institute. The symposium will be held on the second floor of Stewart Center.